Filing Details
- Accession Number:
- 0000905148-19-000831
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-27 16:30:17
- Reporting Period:
- 2019-08-23
- Accepted Time:
- 2019-08-27 16:30:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
70318 | Tenet Healthcare Corp | THC | Services-General Medical & Surgical Hospitals, Nec (8062) | 952557091 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1138995 | Glenview Capital Management, Llc | 767 Fifth Avenue 44Th Floor New York NY 10153 | No | No | No | No | |
1228603 | Larry Robbins | 767 Fifth Avenue 44Th Floor New York NY 10153 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.05 Par Value | Acquisiton | 2019-08-23 | 81,368 | $20.70 | 19,439,259 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnotes |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.05 Par Value | 52,394 | Direct |
Footnotes
- These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were purchased by Glenview Capital Partners, L.P. and Glenview Capital Master Fund, Ltd. in the following amounts: 8,560 Shares were purchased by Glenview Capital Partners, L.P. and 72,808 were purchased by Glenview Capital Master Fund, Ltd.
- These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC.
- Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on August 23, 2019 within a $1.00 range. The actual prices for these transactions range from $20.66 to $20.70, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price.
- Includes 25,728 vested restricted stock units ("RSUs") that will be settled in Shares on May 5, 2020. Each RSU is the economic equivalent of one Share.